The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical trial that looks at removing a key protein from the brain to prevent memory loss at least a d... Read more
Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer’s disease in an animal model. Their findings are published in t... Read more
Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts fail Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted t... Read more
“If these results are replicated in Alzheimer’s disease patients, it would open up a promising avenue of treatment of this devastating neurodegenerative disease.” Buphenyl, an FDA-approved m... Read more
